Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Operating activities
Net loss	$ (4,896,138)	$ (8,757,704)
Adjustments to reconcile net loss to net cash used in operating activities:
Forgiveness of paycheck protection loan and accrued interest	(105,130)
Stock-based compensation expense	960,759	673,117
Change in operating assets and liabilities:
Accounts receivable, net	(175,100)
Prepaid expenses, inventory and other assets	703,867	455,131
Accounts payable and other current liabilities	(805,318)	(495,878)
Accrued compensation	(394,756)	17,359
Accrued interest expense	248,208
Milestone payable		5,000,000
Net cash used in operating activities	(4,463,608)	(3,107,975)
Financing activities
Proceeds from issuance of common stock, net	13,070,154	3,309,116
Proceeds from issuance of common stock from exercise of stock options	45,454
Proceeds from issuance of common stock from employee stock purchase plan		21,250
Proceeds from paycheck protection program		104,168
Proceeds from Eversana line of credit		2,000,000
Net cash provided by financing activities	13,115,608	5,434,534
Net increase in cash and cash equivalents	8,652,000	2,326,559
Cash and cash equivalents at beginning of period	8,068,939	5,663,833
Cash and cash equivalents at end of period	16,720,939	$ 7,990,392
Non-cash financing activities
Forgiveness of paycheck protection loan and accrued interest	$ 105,130